Cargando…

Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

PURPOSE: To investigate the comparative efficacies of the five most commonly used bisphosphonates for the secondary prevention of osteoporotic fractures in a Bayesian network meta-analysis. METHODS: Five databases and the reference lists of all acquired articles from inception to July 2017 were sear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Lei, Min, Nan, Wang, Fei, Xue, Qing-Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885847/ https://www.ncbi.nlm.nih.gov/pubmed/31828096 http://dx.doi.org/10.1155/2019/2594149

Ejemplares similares

The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
por: Byun, Ji-Hye, et al.
Publicado: (2017)

Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysis
por: Peng, Jing, et al.
Publicado: (2016)

Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures
por: Seo, Joong-Bae, et al.
Publicado: (2016)

Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures
por: Aypak, Cenk, et al.
Publicado: (2022)

Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
por: Kim, Hong Jin, et al.
Publicado: (2023)

Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
por: Ke, Cheng‐hui, et al.
Publicado: (2021)

BISPHOSPHONATE-INDUCED MAXILLOFACIAL OSTEONECROSIS IN OSTEOPOROTIC INDIVIDUALS
por: da Silva Santos, Paulo Sérgio, et al.
Publicado: (2015)

The effects of bisphosphonates on osteoporotic patients after lumbar fusion: a meta-analysis
por: Liu, Wen-bin, et al.
Publicado: (2018)

Assessing the Effectiveness of Bisphosphonates for the Prevention of Fragility Fractures: An Updated Systematic Review and Network Meta‐Analyses
por: Bastounis, Anastasios, et al.
Publicado: (2022)

A Case Report of Bisphosphonate-induced Bilateral Osteoporotic Subtrochanteric Fracture Femurii: Review of Literature
por: Uppin, Rajendra, et al.
Publicado: (2016)

Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
por: Cho, Yoon Je, et al.
Publicado: (2015)

Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies
por: Mak, Anselm, et al.
Publicado: (2009)

Prevention of bisphosphonate-related mandibular fractures
por: Pedrazzoli, M., et al.
Publicado: (2016)

Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Clinical efficacy and safety of drug interventions for primary and secondary prevention of osteoporotic fractures in postmenopausal women: Network meta-analysis followed by factor and cluster analysis
por: Wen, Fei, et al.
Publicado: (2020)

Nonpharmacological prevention of osteoporotic fractures
por: Kessenich, Cathy R
Publicado: (2007)

Which is best for osteoporotic vertebral compression fractures: balloon kyphoplasty, percutaneous vertebroplasty or non-surgical treatment? A study protocol for a Bayesian network meta-analysis
por: Kan, Shun-Li, et al.
Publicado: (2017)

A meta-analysis of the secondary fractures for osteoporotic vertebral compression fractures after percutaneous vertebroplasty
por: Zhai, Gongwei, et al.
Publicado: (2021)

Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials
por: Jin, Yuan-Zhe, et al.
Publicado: (2019)

Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment
por: Yeh, Wen-Ling, et al.
Publicado: (2017)

Adherence of bisphosphonate and decreased risk of clinical vertebral fracture in osteoporotic patients: A propensity score matching analysis
por: Kim, Seihee, et al.
Publicado: (2022)

Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype
por: Tummolo, Albina, et al.
Publicado: (2013)

Risk Factors of New Adjacent Compression Fracture after Percutaneous Vertebroplasty: Effectiveness of Bisphosphonate in Osteoporotic or Osteopenic Elderly Patients
por: Seo, Dae-Hyun, et al.
Publicado: (2014)

Prevention and Treatment of Multiple Osteoporotic Compression Fracture
por: Park, Ye-Soo, et al.
Publicado: (2014)

Risk factors for secondary fractures to percutaneous vertebroplasty for osteoporotic vertebral compression fractures: a systematic review
por: Mao, Wei, et al.
Publicado: (2021)

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
por: Eekman, Danielle A, et al.
Publicado: (2011)

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
por: Iwamoto, Jun, et al.
Publicado: (2014)

OA08 Atypical femoral fracture secondary to long term bisphosphonate use; are we doing enough to prevent it?
por: Raj, Arjun, et al.
Publicado: (2023)

Bisphosphonates Versus Denosumab for Prevention of Pathological Fracture in Advanced Cancers With Bone Metastasis: A Meta-analysis of Randomized Controlled Trials
por: Al Farii, Humaid, et al.
Publicado: (2020)

Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis
por: Bastounis, A., et al.
Publicado: (2022)

Effect of an osteoporotic fracture prevention program on fracture incidence in routine care: a cluster-randomized trial
por: Rapp, Kilian, et al.
Publicado: (2022)

Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions
por: Zimmermann, Elizabeth A., et al.
Publicado: (2016)

Characteristics of bone biochemical indices in predicting secondary osteoporotic fracture after intertrochanteric fracture in elderly women
por: Yang, Shaofeng, et al.
Publicado: (2017)

Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients?
por: Lasco, Antonino, et al.
Publicado: (2012)

PROFILE OF PATIENTS WITH OSTEOPOROTIC FRACTURES AND FACTORS THAT DECREASE PREVENTION
por: Xavier, Renato Martins, et al.
Publicado: (2019)

Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials
por: Yang, Yan, et al.
Publicado: (2018)

Bisphosphonates and Atypical Fractures of Femur
por: Yli-Kyyny, Tero
Publicado: (2011)

Atypical femoral fractures and bisphosphonates
por: Jawad, Ali S. M.
Publicado: (2017)

Primary and secondary osteoporotic fractures prophylaxis: evaluation of a prospective cohort()
por: Souza, Bruno Gonçalves Schröder e, et al.
Publicado: (2017)

Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study
por: Iwata, Akira, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q3veb6daobb6viqgvthv7svs0q